Global Brucellosis Vaccines Market Research Report 2025(Status and Outlook)
Description
Report Overview
Brucellosis vaccines are immunobiological preparations designed to prevent brucellosis, a zoonotic disease caused by *Brucella* bacteria, primarily affecting livestock such as cattle, sheep, goats, and pigs, with potential transmission to humans. These vaccines aim to induce immunity, reducing infection rates and economic losses in livestock production. Key products include live attenuated vaccines like *Brucella abortus* strain 19 and RB51 for cattle, *Brucella melitensis* Rev-1 for small ruminants, and inactivated or subunit vaccines under development for enhanced safety. The market is driven by the high prevalence of brucellosis in developing regions, stringent livestock health regulations, and growing awareness of zoonotic risks. However, challenges include vaccine stability, differentiation between infected and vaccinated animals (DIVA compliance), and limited access in rural areas. Growth opportunities lie in advancements in vaccine technology, government-led eradication programs, and increasing demand for animal protein, particularly in Asia, Africa, and Latin America. Major players include Zoetis, Merck Animal Health, and CEVA Santé Animale, with research focusing on next-generation vaccines to improve efficacy and safety profiles.
The global Brucellosis Vaccines market size was estimated at USD 12.29 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.74% during the forecast period.
This report provides a deep insight into the global Brucellosis Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Brucellosis Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Brucellosis Vaccines market in any manner.
Global Brucellosis Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier and Biologicos Laverlam
Biovet
Market Segmentation (by Type)
S19 Vaccine
RB51 Vaccine Strain
Market Segmentation (by Application)
Cattle
Sheep
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Brucellosis Vaccines Market
Overview of the regional outlook of the Brucellosis Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Brucellosis Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Brucellosis Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Brucellosis vaccines are immunobiological preparations designed to prevent brucellosis, a zoonotic disease caused by *Brucella* bacteria, primarily affecting livestock such as cattle, sheep, goats, and pigs, with potential transmission to humans. These vaccines aim to induce immunity, reducing infection rates and economic losses in livestock production. Key products include live attenuated vaccines like *Brucella abortus* strain 19 and RB51 for cattle, *Brucella melitensis* Rev-1 for small ruminants, and inactivated or subunit vaccines under development for enhanced safety. The market is driven by the high prevalence of brucellosis in developing regions, stringent livestock health regulations, and growing awareness of zoonotic risks. However, challenges include vaccine stability, differentiation between infected and vaccinated animals (DIVA compliance), and limited access in rural areas. Growth opportunities lie in advancements in vaccine technology, government-led eradication programs, and increasing demand for animal protein, particularly in Asia, Africa, and Latin America. Major players include Zoetis, Merck Animal Health, and CEVA Santé Animale, with research focusing on next-generation vaccines to improve efficacy and safety profiles.
The global Brucellosis Vaccines market size was estimated at USD 12.29 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.74% during the forecast period.
This report provides a deep insight into the global Brucellosis Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Brucellosis Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Brucellosis Vaccines market in any manner.
Global Brucellosis Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier and Biologicos Laverlam
Biovet
Market Segmentation (by Type)
S19 Vaccine
RB51 Vaccine Strain
Market Segmentation (by Application)
Cattle
Sheep
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Brucellosis Vaccines Market
Overview of the regional outlook of the Brucellosis Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Brucellosis Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Brucellosis Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
158 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Brucellosis Vaccines
- 1.2 Key Market Segments
- 1.2.1 Brucellosis Vaccines Segment By Type
- 1.2.2 Brucellosis Vaccines Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Brucellosis Vaccines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Brucellosis Vaccines Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Brucellosis Vaccines Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Brucellosis Vaccines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Brucellosis Vaccines Product Life Cycle
- 3.3 Global Brucellosis Vaccines Sales By Manufacturers (2020-2025)
- 3.4 Global Brucellosis Vaccines Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Brucellosis Vaccines Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Brucellosis Vaccines Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Brucellosis Vaccines Market Competitive Situation And Trends
- 3.8.1 Brucellosis Vaccines Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Brucellosis Vaccines Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Brucellosis Vaccines Industry Chain Analysis
- 4.1 Brucellosis Vaccines Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Brucellosis Vaccines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Brucellosis Vaccines Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Brucellosis Vaccines Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Brucellosis Vaccines Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Brucellosis Vaccines Sales Market Share By Type (2020-2025)
- 6.3 Global Brucellosis Vaccines Market Size Market Share By Type (2020-2025)
- 6.4 Global Brucellosis Vaccines Price By Type (2020-2025)
- 7 Brucellosis Vaccines Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Brucellosis Vaccines Market Sales By Application (2020-2025)
- 7.3 Global Brucellosis Vaccines Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Brucellosis Vaccines Sales Growth Rate By Application (2020-2025)
- 8 Brucellosis Vaccines Market Sales By Region
- 8.1 Global Brucellosis Vaccines Sales By Region
- 8.1.1 Global Brucellosis Vaccines Sales By Region
- 8.1.2 Global Brucellosis Vaccines Sales Market Share By Region
- 8.2 Global Brucellosis Vaccines Market Size By Region
- 8.2.1 Global Brucellosis Vaccines Market Size By Region
- 8.2.2 Global Brucellosis Vaccines Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Brucellosis Vaccines Sales By Country
- 8.3.2 North America Brucellosis Vaccines Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Brucellosis Vaccines Sales By Country
- 8.4.2 Europe Brucellosis Vaccines Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Brucellosis Vaccines Sales By Region
- 8.5.2 Asia Pacific Brucellosis Vaccines Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Brucellosis Vaccines Sales By Country
- 8.6.2 South America Brucellosis Vaccines Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Brucellosis Vaccines Sales By Region
- 8.7.2 Middle East And Africa Brucellosis Vaccines Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Brucellosis Vaccines Market Production By Region
- 9.1 Global Production Of Brucellosis Vaccines By Region(2020-2025)
- 9.2 Global Brucellosis Vaccines Revenue Market Share By Region (2020-2025)
- 9.3 Global Brucellosis Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Brucellosis Vaccines Production
- 9.4.1 North America Brucellosis Vaccines Production Growth Rate (2020-2025)
- 9.4.2 North America Brucellosis Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Brucellosis Vaccines Production
- 9.5.1 Europe Brucellosis Vaccines Production Growth Rate (2020-2025)
- 9.5.2 Europe Brucellosis Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Brucellosis Vaccines Production (2020-2025)
- 9.6.1 Japan Brucellosis Vaccines Production Growth Rate (2020-2025)
- 9.6.2 Japan Brucellosis Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Brucellosis Vaccines Production (2020-2025)
- 9.7.1 China Brucellosis Vaccines Production Growth Rate (2020-2025)
- 9.7.2 China Brucellosis Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Jinyu
- 10.1.1 Jinyu Basic Information
- 10.1.2 Jinyu Brucellosis Vaccines Product Overview
- 10.1.3 Jinyu Brucellosis Vaccines Product Market Performance
- 10.1.4 Jinyu Business Overview
- 10.1.5 Jinyu Swot Analysis
- 10.1.6 Jinyu Recent Developments
- 10.2 Colorado Serum
- 10.2.1 Colorado Serum Basic Information
- 10.2.2 Colorado Serum Brucellosis Vaccines Product Overview
- 10.2.3 Colorado Serum Brucellosis Vaccines Product Market Performance
- 10.2.4 Colorado Serum Business Overview
- 10.2.5 Colorado Serum Swot Analysis
- 10.2.6 Colorado Serum Recent Developments
- 10.3 Boehringer Ingelheim
- 10.3.1 Boehringer Ingelheim Basic Information
- 10.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Overview
- 10.3.3 Boehringer Ingelheim Brucellosis Vaccines Product Market Performance
- 10.3.4 Boehringer Ingelheim Business Overview
- 10.3.5 Boehringer Ingelheim Swot Analysis
- 10.3.6 Boehringer Ingelheim Recent Developments
- 10.4 Biogenesis-bago
- 10.4.1 Biogenesis-bago Basic Information
- 10.4.2 Biogenesis-bago Brucellosis Vaccines Product Overview
- 10.4.3 Biogenesis-bago Brucellosis Vaccines Product Market Performance
- 10.4.4 Biogenesis-bago Business Overview
- 10.4.5 Biogenesis-bago Recent Developments
- 10.5 Vetal Company
- 10.5.1 Vetal Company Basic Information
- 10.5.2 Vetal Company Brucellosis Vaccines Product Overview
- 10.5.3 Vetal Company Brucellosis Vaccines Product Market Performance
- 10.5.4 Vetal Company Business Overview
- 10.5.5 Vetal Company Recent Developments
- 10.6 Cz Veterinaria
- 10.6.1 Cz Veterinaria Basic Information
- 10.6.2 Cz Veterinaria Brucellosis Vaccines Product Overview
- 10.6.3 Cz Veterinaria Brucellosis Vaccines Product Market Performance
- 10.6.4 Cz Veterinaria Business Overview
- 10.6.5 Cz Veterinaria Recent Developments
- 10.7 Syva Laboratorios
- 10.7.1 Syva Laboratorios Basic Information
- 10.7.2 Syva Laboratorios Brucellosis Vaccines Product Overview
- 10.7.3 Syva Laboratorios Brucellosis Vaccines Product Market Performance
- 10.7.4 Syva Laboratorios Business Overview
- 10.7.5 Syva Laboratorios Recent Developments
- 10.8 Indian Immunologicals
- 10.8.1 Indian Immunologicals Basic Information
- 10.8.2 Indian Immunologicals Brucellosis Vaccines Product Overview
- 10.8.3 Indian Immunologicals Brucellosis Vaccines Product Market Performance
- 10.8.4 Indian Immunologicals Business Overview
- 10.8.5 Indian Immunologicals Recent Developments
- 10.9 Qilu
- 10.9.1 Qilu Basic Information
- 10.9.2 Qilu Brucellosis Vaccines Product Overview
- 10.9.3 Qilu Brucellosis Vaccines Product Market Performance
- 10.9.4 Qilu Business Overview
- 10.9.5 Qilu Recent Developments
- 10.10 Tecnovax
- 10.10.1 Tecnovax Basic Information
- 10.10.2 Tecnovax Brucellosis Vaccines Product Overview
- 10.10.3 Tecnovax Brucellosis Vaccines Product Market Performance
- 10.10.4 Tecnovax Business Overview
- 10.10.5 Tecnovax Recent Developments
- 10.11 Hester Biosciences
- 10.11.1 Hester Biosciences Basic Information
- 10.11.2 Hester Biosciences Brucellosis Vaccines Product Overview
- 10.11.3 Hester Biosciences Brucellosis Vaccines Product Market Performance
- 10.11.4 Hester Biosciences Business Overview
- 10.11.5 Hester Biosciences Recent Developments
- 10.12 Zoetis
- 10.12.1 Zoetis Basic Information
- 10.12.2 Zoetis Brucellosis Vaccines Product Overview
- 10.12.3 Zoetis Brucellosis Vaccines Product Market Performance
- 10.12.4 Zoetis Business Overview
- 10.12.5 Zoetis Recent Developments
- 10.13 Onderstepoort Biological
- 10.13.1 Onderstepoort Biological Basic Information
- 10.13.2 Onderstepoort Biological Brucellosis Vaccines Product Overview
- 10.13.3 Onderstepoort Biological Brucellosis Vaccines Product Market Performance
- 10.13.4 Onderstepoort Biological Business Overview
- 10.13.5 Onderstepoort Biological Recent Developments
- 10.14 Instituto Rosenbusch
- 10.14.1 Instituto Rosenbusch Basic Information
- 10.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Overview
- 10.14.3 Instituto Rosenbusch Brucellosis Vaccines Product Market Performance
- 10.14.4 Instituto Rosenbusch Business Overview
- 10.14.5 Instituto Rosenbusch Recent Developments
- 10.15 Ceva Sante Animale
- 10.15.1 Ceva Sante Animale Basic Information
- 10.15.2 Ceva Sante Animale Brucellosis Vaccines Product Overview
- 10.15.3 Ceva Sante Animale Brucellosis Vaccines Product Market Performance
- 10.15.4 Ceva Sante Animale Business Overview
- 10.15.5 Ceva Sante Animale Recent Developments
- 10.16 Calier And Biologicos Laverlam
- 10.16.1 Calier And Biologicos Laverlam Basic Information
- 10.16.2 Calier And Biologicos Laverlam Brucellosis Vaccines Product Overview
- 10.16.3 Calier And Biologicos Laverlam Brucellosis Vaccines Product Market Performance
- 10.16.4 Calier And Biologicos Laverlam Business Overview
- 10.16.5 Calier And Biologicos Laverlam Recent Developments
- 10.17 Biovet
- 10.17.1 Biovet Basic Information
- 10.17.2 Biovet Brucellosis Vaccines Product Overview
- 10.17.3 Biovet Brucellosis Vaccines Product Market Performance
- 10.17.4 Biovet Business Overview
- 10.17.5 Biovet Recent Developments
- 11 Brucellosis Vaccines Market Forecast By Region
- 11.1 Global Brucellosis Vaccines Market Size Forecast
- 11.2 Global Brucellosis Vaccines Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Brucellosis Vaccines Market Size Forecast By Country
- 11.2.3 Asia Pacific Brucellosis Vaccines Market Size Forecast By Region
- 11.2.4 South America Brucellosis Vaccines Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Brucellosis Vaccines By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Brucellosis Vaccines Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Brucellosis Vaccines By Type (2026-2033)
- 12.1.2 Global Brucellosis Vaccines Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Brucellosis Vaccines By Type (2026-2033)
- 12.2 Global Brucellosis Vaccines Market Forecast By Application (2026-2033)
- 12.2.1 Global Brucellosis Vaccines Sales (K Mt) Forecast By Application
- 12.2.2 Global Brucellosis Vaccines Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.